UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000005257
Receipt No. R000006254
Official scientific title of the study Clinical trial of Bezafibrate for patients with long-chain fatty acid beta-oxydation disorder
Date of disclosure of the study information 2011/04/01
Last modified on 2018/12/14 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Clinical trial of Bezafibrate for patients with long-chain fatty acid beta-oxydation disorder
Title of the study (Brief title) Clinical trial of Bezafibrate for patients with long-chain fatty acid beta-oxydation disorder
Region
Japan

Condition
Condition long-chain fatty acid beta-oxydation disorder
Classification by specialty
Pediatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 to investigate the effects of bezafibrate on patients with long-chain fatty acid beta-oxydation disorder
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes improvement of clinical symptoms (muscle pain etc.)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -but assessor(s) are blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 bezafibrate for internal use
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients with long-chain fatty acid beta-oxydation disorder
Key exclusion criteria a case who dosen't approve this clinical trial
Target sample size 2

Research contact person
Name of lead principal investigator Hiroyuki Awano
Organization Kobe University Graduate School of Medicine
Division name Psdiatrics
Address 7-5-1,Kusunokicho, Chuo, Kobe, Japan
TEL 078-382-6090
Email awahiro@med.kobe-u.ac.jp

Public contact
Name of contact person Hiroyuki Awano
Organization Kobe University Graduate School of Medicine
Division name Pediatrics
Address 7-5-1, Kusunokicho, Chuo, Kobe, Japan
TEL 078-382-6090
Homepage URL
Email awahiro@med.kobe-u.ac.jp

Sponsor
Institute Department of Pediatrics, Kobe University Graduate School of Medicine,
Institute
Department

Funding Source
Organization Grant-in aid for Scientific Resaerch (KAKENHI)
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 04 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 02 Month 01 Day
Anticipated trial start date
2011 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2011 Year 03 Month 16 Day
Last modified on
2018 Year 12 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006254